AI Terminal
MPH Health Care
Earnings Release • May 27, 2016
5425_rns_2016-05-27_c0d9ac8d-6e5d-4fac-9601-7907e1a17adc.html
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 27 May 2016 08:00
MPH Mittelständische Pharma Holding AG: Preliminary IFRS results for first quarter 2016: Net profit EUR 8.69 million (20 Cent per share), equity EUR 147.71 million (3.45 EUR per share)
DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): Quarter Results
2016-05-27 / 08:00
The issuer is solely responsible for the content of this announcement.
MPH Mittelständische Pharma Holding AG:
Preliminary IFRS results for first quarter 2016:
Net profit EUR 8.69 million (20 Cent per share), equity EUR 147.71 million (3.45 EUR per share)
MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), reports its preliminary IFRS Group results for the first quarter 2016.
In the first quarter 2016 the preliminary IFRS Group net profit amounted to EUR 8.69 million (previous year period: EUR 1.26 million).
MPH reports as an investment entity according to IFRS 10 since December 31, 2015. In the transition accounting as of 31 st December 2015 beforehand unrealised reserves were raised to the amount of EUR 74.71 million. This was a dominant factor for the net profit of totally EUR 84.10 million in year 2015.
The listed shares (Frankfurt Stock Exchange) of our investments HAEMATO AG, M1 Beauty AG, and CR Capital Real Estate AG are valued in the MPH reporting at the XETRA closing price at the end of each quarter. In the first quarter 2016 the share price developments were dominant for the net profit of EUR 8.69 million. The equity increased from 3.25 EUR as of 31 st December 2015 to 3.45 EUR as of 31 st March 2016.
The successful development of the operations is reflected in good share price developments. HAEMATO achieved in the first quarter a sales growth of +50% and doubled the profit compared to the prior year period.
A dividend payment of 30 Cents per share was again proposed.
M1 announced the start of dividend payments with an initial dividend proposal of 30 Cents per share.
“We see pleasant results from the effort to perform a contribution towards maintaining healthcare affordable and are looking confident towards a continuing positive profit development in year 2016”, say Patrick Brenske and Dr. Christian Pahl, Members of the Management Board of MPH.
About MPH Mittelständische Pharma Holding AG:
MPH AG is an investment entity strategically focused on the purchase, development and sale of companies and shares in companies especially from the growth segments of the healthcare market. This includes insurance reimbursed segments as well as privately financed segments. But also beyond the healthcare market MPH makes use of potentials of high growth areas.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
Contact:
Juliane Warning
MPH Mittelständische Pharma Holding AG
Grünauer Straße 5
D-12557 Berlin
Phone: +49 (0) 30 897308660 Fax: +49 (0) 30 897308669
E-Mail: [email protected] Web: www.mph-ag.de
2016-05-27 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | MPH Mittelständische Pharma Holding AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | 030 / 897 308 660 |
| Fax: | 030 / 897 308 669 |
| E-mail: | [email protected] |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A0L1H32 |
| WKN: | A0L1H3 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt |
| End of News | DGAP News Service |